Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study

NCT02632903 is registered in ClinicalTrials.gov with Children's Hospital of Eastern Ontario as lead sponsor.

NCT NCT02632903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02632903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study
Lead sponsor
Children's Hospital of Eastern Ontario
Phase
Phase 2
Overall status
Withdrawn
Start date
October 31, 2016
Completion date
August 20, 2018
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, osteonecrosis, osteoporosis